medigraphic.com
ISSN 2007-6800 (Print)

2014, Number 2

<< Back

Rev Mex Traspl 2014; 3 (2)

Spontaneous rupture of renal graft secondary to acute humoral rejection in cadaveric donor transplantation. A case report and literature review

Zaragoza-Salas TA, Escalona-Delgado MS, Rogel-Rodríguez JF, Sámano-Gómez A

Language: Spanish
References: 29
Page: 66-69
PDF size: 212.51 Kb.


ABSTRACT

Kidney transplantation has become the treatment of choice for ESRD. The early vascular rejection is intense event occurring between days three and five after transplantation, and reflects the presensitization host to the donor. It occurs most often in patients with high immunological risk. We report the case of a male patient of 23 years old which is subjected to cadaveric donor transplantation presents humoral acute rejection at 11 postoperative days, which is manifested by spontaneous rupture. Literature is reviewed in order to find reports of similar cases.


REFERENCES

  1. Vázquez ME. Patología crónica del injerto renal. Nefrología. 2008; 28 (4): 373-380.

  2. Averi RK. Prophylactic strategies before solid-organ transplantation. Curr Opin Infect Dis. 2004; 17: 353-356.

  3. Vázquez ME, Veiga BJ. Patología del trasplante renal. Importancia de la biopsia en la correlación clinico-patológica. Rev Esp Patol. 2002; 35 (3): 279-294.

  4. Oppenheimer FS, Arias M. Individualización de la inmunosupresión en el rechazo agudo. Nefrología Suplemento Extraordinario. 2009; 29 (2): 4-9.

  5. Lluís Guirado. El donante incompatible en trasplante renal de donante vivo. Nefrología Suplemento extraordinario. 2010; 30(Suppl. 2): 94-9.

  6. Daar AS, Salahudeen AK, Pingle A. Ethics and commerce in live donor renal transplantation: classification of live donor. Transplantation Proceeding. 2000; 22: 922-924.

  7. Pérez RA, Mármol SA, Pérez de Prado VJC, Fong BA, Fernández-Vega GS. Acute subclinical rejection in the patient with kidney transplant. N Eng J Med. 2008; 353: 2342-2351.

  8. Barba AJ, Rincón MA, Tolosa EE, Romero VL, Rosell CD, Robles GJE et al. Complicaciones quirúrgicas en el trasplante renal y su influencia en la supervivencia del injerto. Actas Urológicas Españolas. 2013; 34 (3): 266-273.

  9. Arce J, Rosalesa A, Caffarattia J, Montlleó AM, Guirado BL, Díaz BJM, Villavicencio AH. Renal retransplantation: risk factors and results. Actas Urológicas Españolas. 2011; 35 (1): 44-50.

  10. The 2009 Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline, American Journal of Transplantation 2009; 9 (Suppl 3): S1–S157 © 2009 The AuthorsWiley Periodicals Inc.

  11. Colvin RB. Chronic allograft nephropathy. N Engl J Med. 2003; 394 (24): 2288-2290.

  12. Remuzzi G, Cravedi P, Perna A, Dimitrov BD, Turturro M, Locatelli G et al. Long-term outcome of renal transplantation from older donors. N Engl J Med. 2006; 354 (4): 343-352.

  13. Kambham N, Nagarajan S, Shah S et al. A novel, semiquantitative, clinically correlated calcineurin inhibitor toxicity score for renal allograft biopsies. Clin J Am Soc Nephrol. 2007; 2: 135-142.

  14. Caillard S, Dharnidharka V, Agodoa L. Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression. Transplantation. 2005; 80 (9): 1233-1243.

  15. Dharnidharka VR, Caillard S, Agodoa LY. Infection frequency and profile in different age groups of kidney transplant recipients. Transplantation. 2006; 81 (12): 1662-1667.

  16. Sung R, Guidinger MK, Lake CD. Impact of the expanded criteria donor allocation system on the use of expanded criteria donor kidneys. Transplantation. 2005; 15 (79): 1257-1261.

  17. Montagnino G, Tarantino A, Maccario M, Elli A, Cesana B, Ponticelli C. Long-term results with cyclosporine monotherapy in renal transplant patients: a multivariate analysis of risk factors. Am J Kidney Dis. 2000; 35: 1135-1143.

  18. Minervini MI, Torbenson M, Scantlebury V, Vivas C, Jordan M, Shapiro R et al. Acute renal allograft rejection with severe tubulitis (Banff 1997 grade IB). Am J Surg Pathol. 2000; 24: 553-558.

  19. Hernández D, Miquel R, Porrini E, Fernández A, González-Posada JM, Torres A. Randomized controlled study comparing reduced calcineurin inhibitors exposure versus standard cyclosporine-based immunosuppression Transplantation. 2007; 84: 706-714.

  20. Brennan DC, Daller JA, Lake KD, Cibrik D, Del Castillo D, for the Thymoglobulin Induction Study Group. Rabbit antithymocyte globulin versus basiliximab in renal transplantation. N Engl J Med. 2006; 355 (19): 1967-1977.

  21. González E, Gutiérrez E, Hernández Y, Roselló G, Gutiérrez MJ, Martínez EG et al. Anti-CD25 monoclonal antibody sequential immunosuppressive induction therapy in renal transplants with high risk of delayed graft function. Transplant Proc. 2005; 37: 3736-3737.

  22. Tanabe K. Japanese experience of ABO-incompatible living kidney transplantation. Transplantation. 2007; 84: S4-S7.

  23. Tydén G, Donauer J, Wadström J, Kumlien G, Wilpert J et al. Implementation of a Protocol for ABO-incompatible kidney transplantation- a three-center experience with 60 consecutive transplantations. Transplantation. 2007; 83: 1153-1155.

  24. Toki D, Ishida H, Horita S, Setoguchi K, Yamaguchi Y et al. Impact of low-dose rituximab on splenic B cells in ABO-incompatible renal transplant recipients. Transpl Int. 2009; 22: 447-454.

  25. Futterman LG. Presumed consent: the solution to the critical organ donor shortage. Am J Crit Care. 1995; 4 (5): 383-388.

  26. Cosio FG, Grande JP, Wadei H, Larson TS, Griffin MD, Stegall MD. Predicting subsequent decline in kidney allograft function from early surveillance biopsies. Am J Transplant. 2005; 5: 2464-2472.

  27. Muthukumar T, Dadhania D, Ding R. Messenger RNA for FOXP3 in the urine of renal-allograft recipient. N Engl J Med. 2005; 353: 2342-2351.

  28. Moreso F, Ibernon M, Goma M. Subclinical rejection associated with chronic allograft nephropathy in protocol biopsias as a risk factor for late grafo loss. Am J Transplant. 2006; 6: 747-752.

  29. Mosquera RJM, Vázquez ME. Criterios diagnósticos de rechazo mediado por anticuerpos en el trasplante renal. Nefrología. 2011; 31 (4): 382-391.




2020     |     www.medigraphic.com